Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENACAPAVIR vs LETROZOLE\RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENACAPAVIR vs LETROZOLE\RIBOCICLIB: Safety Overview

Metric LENACAPAVIR LETROZOLE\RIBOCICLIB
Total FAERS Reports 502 621
Deaths Reported 32 78
Death Rate 6.4% 12.6%
Hospitalizations 42 80
Average Patient Age 50.0 yrs 64.2 yrs
% Female Patients 24.7% 98.2%
FDA Approval Date Dec 22, 2022 N/A
Manufacturer Gilead Sciences, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A